China · Delayed Price · Currency is CNY BMC Medical Statistics
Total Valuation
BMC Medical has a market cap or net worth of CNY 7.62 billion. The enterprise value is 5.15 billion.
| Market Cap | 7.62B |
| Enterprise Value | 5.15B |
Important Dates
The next estimated earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | May 28, 2025 |
Share Statistics
BMC Medical has 88.87 million shares outstanding. The number of shares has decreased by -0.62% in one year.
| Current Share Class | 88.87M |
| Shares Outstanding | 88.87M |
| Shares Change (YoY) | -0.62% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 31.48% |
| Owned by Institutions (%) | 4.64% |
| Float | 35.47M |
Valuation Ratios
The trailing PE ratio is 36.24 and the forward PE ratio is 32.98.
| PE Ratio | 36.24 |
| Forward PE | 32.98 |
| PS Ratio | 7.26 |
| PB Ratio | 2.55 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | 228.80 |
| P/OCF Ratio | 131.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.85, with an EV/FCF ratio of 154.77.
| EV / Earnings | 24.51 |
| EV / Sales | 4.91 |
| EV / EBITDA | 25.85 |
| EV / EBIT | 29.10 |
| EV / FCF | 154.77 |
Financial Position
The company has a current ratio of 6.09, with a Debt / Equity ratio of 0.10.
| Current Ratio | 6.09 |
| Quick Ratio | 5.69 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.54 |
| Debt / FCF | 9.21 |
| Interest Coverage | 34.85 |
Financial Efficiency
Return on equity (ROE) is 7.43% and return on invested capital (ROIC) is 32.82%.
| Return on Equity (ROE) | 7.43% |
| Return on Assets (ROA) | 3.27% |
| Return on Invested Capital (ROIC) | 32.82% |
| Return on Capital Employed (ROCE) | 5.91% |
| Weighted Average Cost of Capital (WACC) | 7.63% |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | 240,034 |
| Employee Count | 876 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 4.71 |
Taxes
In the past 12 months, BMC Medical has paid 26.08 million in taxes.
| Income Tax | 26.08M |
| Effective Tax Rate | 10.80% |
Stock Price Statistics
The stock price has increased by +33.80% in the last 52 weeks. The beta is 0.66, so BMC Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +33.80% |
| 50-Day Moving Average | 88.92 |
| 200-Day Moving Average | 85.26 |
| Relative Strength Index (RSI) | 45.66 |
| Average Volume (20 Days) | 2,237,925 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMC Medical had revenue of CNY 1.05 billion and earned 210.27 million in profits. Earnings per share was 2.37.
| Revenue | 1.05B |
| Gross Profit | 510.73M |
| Operating Income | 177.10M |
| Pretax Income | 241.54M |
| Net Income | 210.27M |
| EBITDA | 190.06M |
| EBIT | 177.10M |
| Earnings Per Share (EPS) | 2.37 |
Balance Sheet
The company has 2.78 billion in cash and 306.71 million in debt, with a net cash position of 2.48 billion or 27.87 per share.
| Cash & Cash Equivalents | 2.78B |
| Total Debt | 306.71M |
| Net Cash | 2.48B |
| Net Cash Per Share | 27.87 |
| Equity (Book Value) | 2.99B |
| Book Value Per Share | 33.53 |
| Working Capital | 2.68B |
Cash Flow
In the last 12 months, operating cash flow was 57.81 million and capital expenditures -24.50 million, giving a free cash flow of 33.30 million.
| Operating Cash Flow | 57.81M |
| Capital Expenditures | -24.50M |
| Free Cash Flow | 33.30M |
| FCF Per Share | 0.37 |
Margins
Gross margin is 48.66%, with operating and profit margins of 16.87% and 20.03%.
| Gross Margin | 48.66% |
| Operating Margin | 16.87% |
| Pretax Margin | 23.01% |
| Profit Margin | 20.03% |
| EBITDA Margin | 18.11% |
| EBIT Margin | 16.87% |
| FCF Margin | 3.17% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.47%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 0.47% |
| Dividend Growth (YoY) | -60.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 19.99% |
| Buyback Yield | 0.62% |
| Shareholder Yield | 1.10% |
| Earnings Yield | 2.76% |
| FCF Yield | 0.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 29, 2024. It was a forward split with a ratio of 1.4.
| Last Split Date | May 29, 2024 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
BMC Medical has an Altman Z-Score of 9.45 and a Piotroski F-Score of 5.
| Altman Z-Score | 9.45 |
| Piotroski F-Score | 5 |